Royalty Pharma (RPRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

33.690
-0.110-0.33%

Close Feb 25 16:00 ET

14.60BMarket Cap17.64P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Peering Into Royalty Pharma's Recent Short Interest
BenzingaFeb 24 10:00 ET
Royalty Pharma To Go Ex-Dividend On February 21st, 2025 With 0.22 USD Dividend Per Share
Moomoo NewsFeb 19 20:00 ET
Trump Floats 25% Tariffs on Autos, Chips, Pharmaceuticals
WSJFeb 18 18:32 ET
Royalty Pharma's Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition
TipRanksFeb 13 01:00 ET
Royalty Pharma | 10-K: FY2024 Annual Report
SECFeb 12 13:22 ET · Announcements
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
BenzingaFeb 12 09:39 ET

Comments

Royalty Pharma Reports Q4 and Full Year 2024 Results

$Royalty Pharma (RPRX.US)$
Royalty Pharma's Triple Win: 12% Revenue Jump, Massive Buyback, and Strategic Acquisition

Royalty Pharma Reports Q4 and Full Year 2024 Results

$Royalty Pharma (RPRX.US)$

$Royalty Pharma (RPRX.US)$

Dec 23, 2024 11:01

$Royalty Pharma (RPRX.US)$

Nov 4, 2024 15:05

$Syndax Pharmaceuticals (SNDX.US)$ $Royalty Pharma (RPRX.US)$ Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)
Dow Jones· 1 min ago

Read more